Onartuzumab (Anti-HGFR / c-Met)
Onartuzumab (Anti-HGFR / c-Met) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity. MW: 144.64 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2468 |
Sku # | A2468-1mg*25 |
Pricing | 1mg*25, $5070.00 |